NovaTec Immundiagnostica’s assays aid diagnosis of SARS-COV-2
NovaTec provides reliable direct pathogen and antibody detection assays to aid in the diagnosis of SARS-CoV-2. These tests are CE-IVD marked. The development of the assays has been spearheaded by affiliate companies Gold Standard Diagnostics, NovaTec Immundiagnostica, and VIROTECH Diagnostics.
The NovaLisa SARS-CoV-2 (COVID-19) ELISA serological assays feature separate detection of IgG, IgA, and IgM antibodies. These three assays use the nucleocapsid protein (N protein) as antigen for the detection of antibodies to SARS-CoV-2, as it plays an important role in viral pathogenesis, replication and RNA packaging. NovaLisa assays can be automated on several open ELISA systems to provide quick results.
The GSD NovaPrime SARS-CoV-2 is a onestep reverse transcription multiplex Real-Time PCR for the direct detection of SARS-CoV-2. The assay simultaneously detects two target sequences inside the N gene. The multiplex PCR enables a streamlined workflow in one reaction and provides results in approximately 2 hours. An extraction/inhibition control and a positive control are included in the kits. The PCR assay demonstrates excellent performance and no cross-reactivity with common human coronavirus strains.